Home » Topics » BioWorld Science

BioWorld Science
RSS

Yeast study reveals potential cancer therapy approach

July 27, 2021

PolarityTE submits IND for SkinTE in chronic cutaneous ulcers

July 27, 2021

Interim update on first-in-human study of SB-11285 in solid tumors

July 27, 2021

Health Canada approves clinical trials of AT-1501 in kidney transplantation

July 27, 2021

Aurion releases preliminary findings from study of cell therapy for corneal endothelial disease

July 26, 2021

MediWound's MW-005 studied in clinical trials for BCC and nonmelanoma skin cancers

July 26, 2021

FDA clears IND for phase I study of NT-I7 for Kaposi sarcoma

July 26, 2021

Cortexyme selects 3CLpro inhibitor COR-803 to treat coronavirus infections

July 26, 2021

New mouse model created for cerebral venous sinus thrombosis

July 26, 2021

DSMB reviews phase Ib part of ILIAD study of ilixadencel with pembrolizumab in advanced cancers

July 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...